In summary, we successfully fabricated a lysosome activable multifunctional micelle for effective co-delivery of SAHA and siRNA-PD-L1, which aims at combining PD-L1-KD induced cancer immunotherapy and HDACIs chemotherapy to exert a synergetic therapeutic effect on tumor proliferation and metastasis. Here, CD274 is linked to cancer.